Concourse Financial Group Securities’s ANI Pharmaceuticals ANIP Stock Holding History

Concourse Financial Group Securities’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-42	Closed	-$2.23K	–	2158
2019 Q4	$3K	Buy	+42	New	+$2.78K	﹤0.01%	1738
2019 Q3	–	Sell	-42	Closed	-$3.14K	–	1754
2019 Q2	$3K	Hold	42	–	–	﹤0.01%	1857
2019 Q1	$2K	Sell	42 -52	-55%	-$3.06K	﹤0.01%	1995
2018 Q4	$4K	Sell	94 -17	-15%	-$891	﹤0.01%	1705
2018 Q3	$6K	Buy	+111	New	+$6.79K	﹤0.01%	1315

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Concourse Financial Group Securities's ANIP Position: Q1 2020 in Review

Concourse Financial Group Securities sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 42 shares — an estimated $2.23K sold.

Concourse Financial Group Securities first reported a position in ANIP in Q3 2018 and held it in 5 quarters. The position peaked at $6K in Q3 2018. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

Concourse Financial Group Securities reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Concourse Financial Group Securities sold 42 ANI Pharmaceuticals shares in Q1 2020, an estimated $2.23K.
Concourse Financial Group Securities first reported a position in ANI Pharmaceuticals in Q3 2018 and held it in 5 quarters.
Concourse Financial Group Securities's ANI Pharmaceuticals position peaked at $6K in Q3 2018.
140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Concourse Financial Group Securities's 13F filing for Q1 2020, filed 13 May 2020.